1. GPCR/G Protein Immunology/Inflammation Apoptosis
  2. Leukotriene Receptor Interleukin Related TNF Receptor NO Synthase
  3. 2-ARA-LysoPtdEtn

2-ARA-LysoPtdEtn  (Synonyms: 1-Lyso-2-arachidonoyl-sn-glycero-3-phosphoethanolamine)

Cat. No.: HY-185709
Handling Instructions Technical Support

2-ARA-LysoPtdEtn (1-Lyso-2-arachidonoyl-sn-glycero-3-phosphoethanolamine) is an orally active polyunsaturated acyl lysophosphatidylethanolamine. 2-ARA-LysoPtdEtn diminishes formation of LTC4, LTB4, and 12-HETE. 2-ARA-LysoPtdEtn lowers levels of IL-1β, IL-6, TNF-α, and NO. 2-ARA-LysoPtdEtn augments IL-10 levels and upgrades formation of 15-HETE and LXA4. 2-ARA-LysoPtdEtn can be used for the research of peritonitis.

For research use only. We do not sell to patients.

2-ARA-LysoPtdEtn

2-ARA-LysoPtdEtn Chemical Structure

CAS No. : 53847-31-7

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

2-ARA-LysoPtdEtn (1-Lyso-2-arachidonoyl-sn-glycero-3-phosphoethanolamine) is an orally active polyunsaturated acyl lysophosphatidylethanolamine. 2-ARA-LysoPtdEtn diminishes formation of LTC4, LTB4, and 12-HETE. 2-ARA-LysoPtdEtn lowers levels of IL-1β, IL-6, TNF-α, and NO. 2-ARA-LysoPtdEtn augments IL-10 levels and upgrades formation of 15-HETE and LXA4. 2-ARA-LysoPtdEtn can be used for the research of peritonitis[1].

IC50 & Target[1]

IL-1β

 

IL-6

 

LTC4

 

IL-10

 

In Vitro

2-ARA-LysoPtdEtn (0-20 μM) acts as an effective substrate for Glycine max LOX-1B, porcine leukocyte 12/15-LOX, and human recombinant 15-LOX-2, with catalytic efficacy values of 10.9, 10.3, and 14.8 units/mg/μM, respectively[1].
2-ARA-LysoPtdEtn (100 μM; 30 min) is effectively converted by Glycine max LOX-1B into its 15-hydroperoxy derivative, 2-(15-HpETE)-lysoPtdEtn, as identified via LC/ESI-MS[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

2-ARA-lysoPtdEtn (15-150 µg/kg; p.o.; single dose) dose-dependently inhibits Zymosan A (HY-W250113)-induced peritonitis in ICR mice with an ED50 of 221 µg/kg for plasma leakage inhibition and 123 µg/kg for leukocyte infiltration inhibition, while also promoting inflammation resolution[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: ICR mice (4-6 weeks of age, 29-30 g body weight, intraperitoneal injected 1 mg Zymosan A to establish a eritonitis model)[1]
Dosage: 15 µg/kg; 50 µg/kg; 150 µg/kg
Administration: p.o.; single dose
Result: Suppressed Zymosan A-induced plasma leakage by 17% at 50 µg/kg and by 36% at 150 µg/kg; ED50 for plasma leakage inhibition was 221 µg/kg.
Decreased total leukocyte infiltration by 56% at 150 µg/kg; ED50 for leukocyte infiltration inhibition was 123 µg/kg.
Dose-dependently reduced Zymosan A-induced formation of LTC4 (ED50 = 132 µg/kg), LTB4 (ED50 = 139 µg/kg), and 12-HETE.
Dose-dependently reduced Zymosan A-induced levels of pro-inflammatory cytokines TNF-α, IL-1β, and IL-6; increased anti-inflammatory cytokine IL-10 levels by approximately five-fold at 150 µg/kg compared to the Zymosan A-challenged group.
Diminished Zymosan A-induced nitric oxide production by 60% at 50 µg/kg and by 70% at 150 µg/kg.
Dose-dependently increased peritoneal levels of 15-HETE (3.5-fold at 15 µg/kg, 5-fold at 50 µg/kg, 9-fold at 150 µg/kg) and LXA4 (2-fold at 15 µg/kg, 4-fold at 50 µg/kg, 5.5-fold at 150 µg/kg) compared to the Zymosan A-challenged group.
Reduced total leukocyte infiltration by ~23% at 15 hours, ~21% at 20 hours, and ~33% at 24 hours when administered 12 hours after Zymosan A treatment compared to the Zymosan A-alone group.
Molecular Weight

501.59

Formula

C25H44NO7P

CAS No.
SMILES

CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(O[C@H](CO)COP(OCCN)(O)=O)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
2-ARA-LysoPtdEtn
Cat. No.:
HY-185709
Quantity:
MCE Japan Authorized Agent: